Added benefit of saxagliptin/metformin combination is not proven
Wednesday, May 15, 2013 3:13
% of readers think this story is Fact. Add your two cents.
http://www.for-diabetes.com/added-benefit-of-saxagliptinmetformin-combination-is-not-proven
Added benefit of saxagliptin/metformin combination is not proven
The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the “Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this fixed combination product offers an added benefit versus the current standard treatment.
Read More: http://www.for-diabetes.com/added-benefit-of-saxagliptinmetformin-combination-is-not-proven
